Shrunken pore syndrome, preeclampsia, and markers of NO metabolism in pregnant women during the first trimester

References

• Inker LA, Levey AS, Coresh J. Estimated glomerular filtration rate from a panel of filtration markers–hope for increased accuracy beyond measured glomerular filtration rate? Adv Chronic Kidney Dis. 2018;25:67–75.
   PubMed Web of Science ®Google Scholar
• Karger AB, Inker LA, Coresh J. Novel filtration markers for GFR estimation. EJIFCC. 2017;28:277–288.
   PubMedGoogle Scholar
• Grubb A. Cystatin C is indispensable for evaluation of kidney disease. EJIFCC. 2017;28:268–276.
   PubMedGoogle Scholar
• Levey AS, Eckfeldt JH. Estimating glomerular filtration rate using serum creatinine. Clin Chem. 2017;63:1161–1162.
   PubMed Web of Science ®Google Scholar
• Inker LA, Tighiouart H, Coresh J, et al. GFR estimation using β-trace protein and β2-microglobulin in CKD. Am J Kidney Dis. 2016;67:40–48.
   PubMed Web of Science ®Google Scholar
• Bjork J, Grubb A, Sterner G, et al. Revised equations for estimating glomerular filtration rate based on the Lund–Malmö Study cohort. Scand J Clin Lab Invest. 2011;71:232–239.
   PubMed Web of Science ®Google Scholar
• Swan SK. The search continues: an ideal marker of GFR. Clin Chem. 1997;43:913–914.
   PubMed Web of Science ®Google Scholar
• Hosten AO. BUN and creatinine. In: Walker HK, Hall WD, et al, editors. Clinical methods: the history, physical, and laboratory examinations. Boston; 1990.
   Google Scholar
• Purde MT, Nock S, Risch L, et al. The cystatin C/creatinine ratio, a marker of glomerular filtration quality: associated factors, reference intervals, and prediction of morbidity and mortality in healthy seniors. Transl Res. 2016;169:80–90.
   PubMed Web of Science ®Google Scholar
• Kristensen K, Wide-Swensson D, Schmidt C, et al. Cystatin C, beta-2-microglobulin and beta-trace protein in pre-eclampsia. Acta Obstet Gynecol Scand. 2007;86:921–926.
   PubMed Web of Science ®Google Scholar
• Kristensen K, Strevens H, Lindstrom V, et al. Increased plasma levels of beta2-microglobulin, cystatin C and beta-trace protein in term pregnancy are not due to utero-placental production. Scand J Clin Lab Invest. 2008;68:649–653.
   PubMed Web of Science ®Google Scholar
• Kristensen K, Lindstrom V, Schmidt C, et al. Temporal changes of the plasma levels of cystatin C, beta-trace protein, beta2-microglobulin, urate and creatinine during pregnancy indicate continuous alterations in the renal filtration process. Scand J Clin Lab Invest. 2007;67:612–618.
   PubMed Web of Science ®Google Scholar
• Grubb A. Abnormal glomerular filtration quality: a new marker for kidney disease. Use of cystatin C to identify it. In: Edelstein CL, editor. Biomarkers of kidney disease. 1 ed. Amsterdam: Elsevier; 2011. p. 302–304.
   Google Scholar
• Grubb A, Lindstrom V, Jonsson M, et al. Reduction in glomerular pore size is not restricted to pregnant women. Evidence for a new syndrome: 'Shrunken Pore syndrome'. Scand J Clin Lab Invest. 2015;75:333–340.
   PubMed Web of Science ®Google Scholar
• Risch M, Risch L, Purde MT, et al. Association of the cystatin C/creatinine ratio with the renally cleared hormones parathyroid hormone (PTH) and brain natriuretic peptide (BNP) in primary care patients: a cross-sectional study. Scand J Clin Lab Invest. 2016;76:379–385.
   PubMed Web of Science ®Google Scholar
• Grubb A. Cystatin C as a multifaceted biomarker in kidney disease and its role in defining “Shrunken Pore Syndrome”. In: Edelstein CL, editor. Biomarkers of kidney disease. 2nd ed. London: Elsevier; 2017. p. 225–240.
   Google Scholar
• Leion F, Hegbrant J, den Bakker E, et al. Estimating glomerular filtration rate (GFR) in children. The average between a cystatin C- and a creatinine-based equation improves estimation of GFR in both children and adults and enables diagnosing Shrunken Pore Syndrome. Scand J Clin Lab Invest. 2017;77:338–344.
   PubMed Web of Science ®Google Scholar
• Sällman Almén M, Björk J, Nyman U, et al. Shrunken pore syndrome is associated with increased levels of atherosclerosis-promoting proteins. Kidney Int Rep. 2018, In press.
   Web of Science ®Google Scholar
• Dardashti A, Nozohoor S, Grubb A, et al. Shrunken Pore Syndrome is associated with a sharp rise in mortality in patients undergoing elective coronary artery bypass grafting. Scand J Clin Lab Invest. 2016;76:74–81.
   PubMed Web of Science ®Google Scholar
• Christensson A, Grubb A, Molvin J, et al. The shrunken pore syndrome is associated with declined right ventricular systolic function in a heart failure population: the HARVEST study. Scand J Clin Lab Invest. 2016;76:568–574.
   PubMed Web of Science ®Google Scholar
• Risch M, Purde MT, Baumann M, et al. High first-trimester maternal blood cystatin C levels despite normal serum creatinine predict pre-eclampsia in singleton pregnancies. Scand J Clin Lab Invest. 2017;77:634–643.
   PubMed Web of Science ®Google Scholar
• Strevens H, Wide-Swensson D, Grubb A. Serum cystatin C is a better marker for preeclampsia than serum creatinine or serum urate. Scand J Clin Lab Invest. 2001;6:575–580.
   Google Scholar
• Strevens H, Wide-Swensson D, Grubb A, et al. Serum cystatin C reflects glomerular endotheliosis in normal, hypertensive and pre-eclamptic pregnancies. BJOG: Int J Obstet Gynecol. 2003;110:825–830.
   PubMed Web of Science ®Google Scholar
• Strevens H, Wide-Swensson D, Hansen A, et al. Glomerular endotheliosis in normal pregnancy and pre-eclampsia. BJOG. 2003;110:831–836.
   PubMed Web of Science ®Google Scholar
• Strevens H, Wide-Swensson D, Torffvit O, et al. Serum cystatin C for assessment of glomerular filtration rate in pregnant and non-pregnant women. Indications of altered filtration process in pregnancy. Scand J Clin Lab Invest. 2002;62:141–147.
   PubMed Web of Science ®Google Scholar
• Phipps E, Prasanna D, Brima W, et al. Preeclampsia: updates in pathogenesis, definitions, and guidelines. Clin J Am Soc Nephrol. 2016;11:1102–1113.
   PubMed Web of Science ®Google Scholar
• Stuart JJ, Tanz LJ, Missmer SA, et al. Hypertensive disorders of pregnancy and maternal cardiovascular disease risk factor development: an observational cohort study. Ann Intern Med. 2018;169:224–232.
   PubMed Web of Science ®Google Scholar
• Tan MY, Syngelaki A, Poon LC, et al. Screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation. Ultrasound Obstet Gynecol. 2018;52:186–195.
   PubMed Web of Science ®Google Scholar
• Rolnik DL, Wright D, Poon LC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377:613–622.
   PubMed Web of Science ®Google Scholar
• Morris SM. Arginine Metabolism Revisited. J Nutr. 2016;146:2579S–2586S.
   PubMed Web of Science ®Google Scholar
• Tamas P, Bodis J, Sulyok E, et al. l-Arginine metabolism in early-onset and late-onset pre-eclamptic pregnancies. Scand J Clin Lab Invest. 2013;73:436–443.
   PubMed Web of Science ®Google Scholar
• Khalil A, Hardman L, O Brien P. The role of arginine, homoarginine and nitric oxide in pregnancy. Amino Acids. 2015;47:1715–1727.
   PubMed Web of Science ®Google Scholar
• Forstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J. 2012;33:829–837.
   PubMed Web of Science ®Google Scholar
• Leiper J, Vallance P. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc Res. 1999;43:542–548.
   PubMed Web of Science ®Google Scholar
• Cardounel AJ, Cui H, Samouilov A, et al. Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function. J Biol Chem. 2007;282:879–887.
   PubMed Web of Science ®Google Scholar
• Bode-Boger SM, Boger RH, Kienke S, et al. Elevated l-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary l-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Commun. 1996;219:598–603.
   PubMed Web of Science ®Google Scholar
• Brinkmann SJ, Worner EA, Buijs N, et al. The arginine/ADMA ratio is related to the prevention of atherosclerotic plaques in hypercholesterolemic rabbits when giving a combined therapy with atorvastatine and arginine. IJMS. 2015;16:12230–12242.
   Google Scholar
• Richir MC, van Lambalgen AA, Teerlink T, et al. Low arginine/asymmetric dimethylarginine ratio deteriorates systemic hemodynamics and organ blood flow in a rat model. Crit Care Med. 2009;37:2010–2017.
   PubMed Web of Science ®Google Scholar
• van der Zwan LP, Scheffer PG, Dekker JM, et al. Systemic inflammation is linked to low arginine and high ADMA plasma levels resulting in an unfavourable NOS substrate-to-inhibitor ratio: the Hoorn Study. Clin Sci. 2011;121:71–78.
   PubMed Web of Science ®Google Scholar
• Notsu Y, Yano S, Shibata H, et al. Plasma arginine/ADMA ratio as a sensitive risk marker for atherosclerosis: Shimane CoHRE study. Atherosclerosis. 2015;239:61–66.
   PubMed Web of Science ®Google Scholar
• Sasser JM, Murphy SR, Granger JP. Emerging drugs for preeclampsia: the endothelium as a target. Expert Opin Emerg Drugs. 2015;20:527–530.
   PubMed Web of Science ®Google Scholar
• Dorniak-Wall T, Grivell RM, Dekker GA, et al. The role of l-arginine in the prevention and treatment of pre-eclampsia: a systematic review of randomised trials. J Hum Hypertens. 2014;28:230–235.
   PubMed Web of Science ®Google Scholar
• Trapani A, Jr., Goncalves LF, Trapani TF, et al. Perinatal and hemodynamic evaluation of sildenafil citrate for preeclampsia treatment: a randomized controlled trial. Obstet Gynecol. 2016;128:253–259.
   PubMed Web of Science ®Google Scholar
• Gillis EE, Mooney JN, Garrett MR, et al. Sildenafil treatment ameliorates the maternal syndrome of preeclampsia and rescues fetal growth in the Dahl salt-sensitive rat. Hypertension. 2016;67:647–653.
   PubMed Web of Science ®Google Scholar
• Altun ZS, Uysal S, Guner G, et al. Effects of oral l-arginine supplementation on blood pressure and asymmetric dimethylarginine in stress-induced preeclamptic rats. Cell Biochem Funct. 2008;26:648–653.
   PubMed Web of Science ®Google Scholar
• Khalil AA, Tsikas D, Akolekar R, et al. Asymmetric dimethylarginine, arginine and homoarginine at 11–13 weeks' gestation and preeclampsia: a case–control study. J Hum Hypertens. 2013;27:38–43.
   PubMed Web of Science ®Google Scholar
• Purde MT, Baumann M, Wiedemann U, et al. Incidence of preeclampsia in pregnant Swiss women. Swiss Med Wkly. 2015;145:w14175.
   PubMed Web of Science ®Google Scholar
• International Federation of Clinical C, Laboratory M, Working Group on Standardization of Glomerular Filtration Rate A, et al. The importance of metrological traceability on the validity of creatinine measurement as an index of renal function. Clin Chem Lab Med. 2006;44:1287–1292.
   PubMed Web of Science ®Google Scholar
• Grubb A, Blirup-Jensen S, Lindstrom V, et al. First certified reference material for cystatin C in human serum ERM-DA471/IFCC. Clin Chem Lab Med. 2010;48:1619–1621.
   PubMed Web of Science ®Google Scholar
• Veiga S, Wahrheit J, Rodriguez-Martin A, et al. Quantitative metabolomics in Alzheimer's disease: technical considerations for improved reproducibility. Methods Mol Biol. 2018;1779:463–470.
   PubMedGoogle Scholar
• Casanova R, Varma S, Simpson B, et al. Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals. Alzheimers Dement. 2016;12:815–822.
   PubMed Web of Science ®Google Scholar
• Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367:20–29.
   PubMed Web of Science ®Google Scholar
• Pottel H, Delanaye P, Schaeffner E, et al. Estimating glomerular filtration rate for the full age spectrum from serum creatinine and cystatin C. Nephrol Dial Transplant. 2017;32:497–507.
   PubMed Web of Science ®Google Scholar
• Pottel H, Hoste L, Dubourg L, et al. An estimated glomerular filtration rate equation for the full age spectrum. Nephrol Dial Transplant. 2016;31:798–806.
   PubMed Web of Science ®Google Scholar
• CLSI. Defining, establishing and verifying reference intervals in the clinical laboratory; approved guideline. CLSI document EP28-A3c. 3rd ed. Vol. 28. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
   Google Scholar
• Strohle A, von Bibra H, Hahn A. l-Arginine and vascular health. Med Monatsschr Pharm. 2016;39:515–520.
   PubMedGoogle Scholar
• Willeit P, Freitag DF, Laukkanen JA, et al. Asymmetric dimethylarginine and cardiovascular risk: systematic review and meta-analysis of 22 prospective studies. J Am Heart Assoc. 2015;4:e001833.
   PubMed Web of Science ®Google Scholar
• Schlesinger S, Sonntag SR, Lieb W, et al. Asymmetric and symmetric dimethylarginine as risk markers for total mortality and cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. PloS One. 2016;11:e0165811.
   PubMed Web of Science ®Google Scholar
• Luiking YC, Ten Have GA, Wolfe RR, et al. Arginine de novo and nitric oxide production in disease states. Am J Physiol Endocrinol Metab. 2012;303:E1177–E1189.
   PubMed Web of Science ®Google Scholar
• Sibal L, Agarwal SC, Home PD, et al. The role of asymmetric dimethylarginine (ADMA) in endothelial dysfunction and cardiovascular disease. CCR. 2010;6:82–90.
   Google Scholar
• Bian Z, Shixia C, Duan T. First-trimester maternal serum levels of sFLT1, PGF and ADMA predict preeclampsia. PloS One. 2015;10:e0124684.
   PubMed Web of Science ®Google Scholar
• Karampas GA, Eleftheriades MI, Panoulis KC, et al. Prediction of pre-eclampsia combining NGAL and other biochemical markers with Doppler in the first and/or second trimester of pregnancy. A pilot study. Eur J Obstet Gynecol Reprod Biol. 2016;205:153–157.
   PubMed Web of Science ®Google Scholar
• Mannaerts D, Faes E, Gielis J, et al. Oxidative stress and endothelial function in normal pregnancy versus pre-eclampsia, a combined longitudinal and case control study. BMC Pregnancy Childbirth. 2018;18:60.
   PubMed Web of Science ®Google Scholar
• Nemeth B, Ajtay Z, Hejjel L, et al. The issue of plasma asymmetric dimethylarginine reference range: a systematic review and meta-analysis. PloS One. 2017;12:e0177493.
   PubMed Web of Science ®Google Scholar
• Atzler D, Schwedhelm E, Nauck M, et al. Serum reference intervals of homoarginine, ADMA, and SDMA in the study of health in Pomerania. Clin Chem Lab Med. 2014;52:1835–1842.
   PubMed Web of Science ®Google Scholar
• Luneburg N, Xanthakis V, Schwedhelm E, et al. Reference intervals for plasma l-arginine and the l-arginine:asymmetric dimethylarginine ratio in the Framingham Offspring Cohort. J Nutr. 2011;141:2186–2190.
   PubMed Web of Science ®Google Scholar
• Schwedhelm E, Xanthakis V, Maas R, et al. Asymmetric dimethylarginine reference intervals determined with liquid chromatography-tandem mass spectrometry: results from the Framingham offspring cohort. Clin Chem. 2009;55:1539–1545.
   PubMed Web of Science ®Google Scholar
• Speer PD, Powers RW, Frank MP, et al. Elevated asymmetric dimethylarginine concentrations precede clinical preeclampsia, but not pregnancies with small-for-gestational-age infants. Am J Obstet Gynecol. 2008;19:112 e1–117.
   Google Scholar
• Yuan J, Wang X, Xie Y, et al. Circulating asymmetric dimethylarginine and the risk of preeclampsia: a meta-analysis based on 1338 participants. Oncotarget. 2017;8:43944–43952.
   PubMedGoogle Scholar
• Maged M, Wageh A, Shams M, et al. Use of sildenafil citrate in cases of intrauterine growth restriction (IUGR); a prospective trial. Taiwan J Obstet Gynecol. 2018;57:483–486.
   PubMed Web of Science ®Google Scholar
• Hawkes N. Trial of Viagra for fetal growth restriction is halted after baby deaths. BMJ. 2018;362:k3247.
   PubMedGoogle Scholar
• Smith GCS. The STRIDER trial: one step forward, one step back. Lancet Child Adolesc Health. 2018;2:80–81.
   PubMedGoogle Scholar
• Sharp A, Cornforth C, Jackson R, et al. Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial. Lancet Child Adolesc Health. 2018;2:93–102.
   PubMedGoogle Scholar
• Larre AB, Sontag F, Pasin DM, et al. Phosphodiesterase inhibition in the treatment of preeclampsia: what is new? Curr Hypertens Rep. 2018;20:83.
   PubMed Web of Science ®Google Scholar
• Mosimann B, Amylidi-Mohr S, Holand K, et al. Importance of timing first-trimester placental growth factor and use of serial first-trimester placental growth factor measurements in screening for preeclampsia. Fetal Diagn Ther. 2017; 42:111–116.
   PubMed Web of Science ®Google Scholar